Evidence map›Paper›PMID 37884780›Full record

ArticleJournal of endocrinological investigation2024

Hyponatremia, hypernatremia and impairment of functional, psychological and sexual domains.

D Norello, G Rastrelli, L Antonio, G Bartfai, F F Casanueva, A Giwercman, I T Huhtaniemi, T W O'Neill, M Punab, J Slowikowska-Hilczer and 5 more

Abstract read
In one paragraph

Article in Journal of endocrinological investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

D Norello *Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Careggi Hospital, Viale Pieraccini, 6, 50139, Florence, Italy.ORCID http://orcid.org/0000-0001-9784-2287
G Rastrelli *Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Careggi Hospital, Viale Pieraccini, 6, 50139, Florence, Italy.
L AntonioDepartment of Chronic Diseases and Metabolism, Laboratory of Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium.
G BartfaiDepartment of Obstetrics, Gynaecology and Andrology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
F F CasanuevaDepartment of Medicine, CIBER de Fisiopatologıa Obesidad y Nutricion, Santiago de Compostela University, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain.
A GiwercmanDepartment of Translational Medicine, Lund University, Malmö, Sweden.
I T HuhtaniemiDepartment of Metabolism, Digestion and Reproduction, Institute of Reproductive and Developmental Biology, Imperial College London, London, UK.
T W O'NeillCentre for Epidemiology Versus Arthritis, The University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.
M PunabAndrology Clinic, Tartu University Hospital, and Institute of Clinical Medicine, and Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
J Slowikowska-HilczerDepartment of Andrology and Reproductive Endocrinology, Medical University of Łódź, Łódź, Poland.
J TournoyDepartment of Geriatrics, University Hospitals Leuven, and Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
D VanderschuerenDepartment of Chronic Diseases and Metabolism, Laboratory of Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium.
F C W WuDepartment of Endocrinology, Manchester University NHS Foundation Trust, Manchester, UK.
M MaggiDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Careggi Hospital, Viale Pieraccini, 6, 50139, Florence, Italy.
A PeriDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Careggi Hospital, Viale Pieraccini, 6, 50139, Florence, Italy. alessandro.peri@unifi.it.

Funding

Commission of the European Communities Fifth Framework Program QLK6-CT-2001-00258
6 · The paper itself

Abstract

objectiveTo determine the influence of serum sodium on physical, psychologic and sexual function.

methodsThis is a cross-sectional survey on 3340 community-dwelling men aged 40-79 years from a prospective cohort study in eight European countries, the European Male Ageing Study (EMAS). Participants filled-out the Short Form-36 (SF-36), the Physical Activity Scale for the Elderly (PASE), and the EMAS sexual function questionnaire. For all the analyses, serum sodium corrected for glycaemia ([Na

resultsThe relationship between [Na

conclusionsThis is the first study supporting an association between [Na

Indexed as

HypernatremiaHyponatremiaAgedCross-Sectional StudiesHumansMaleProspective StudiesSodiumSodiumErectile dysfunctionHypernatremiaHyponatremiaPhysical functionPsychologic functionSexual function

Identifiers

PMID37884780
PMCPMC10965595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.